Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 11/20 | 0.88 |
| ▸ | CHRM2 known ✓ | P08172 | 5/20 | 0.55 |
| ▸ | CHRM1 known ✓ | P11229 | 5/20 | 0.55 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL4166138 | 1.00 | CHRM3 (0.88) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL141730 | 0.94 | CHRM3 (1.00) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL141731 | 0.94 | CHRM3 (1.00) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL4169332 | 0.81 | CHRM3 (0.67) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL4169330 | 0.81 | CHRM3 (0.67) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL5039534 | 0.81 | CHRM3 (0.74) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL5039532 | 0.81 | CHRM3 (0.74) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL143848 | 0.80 | CHRM3 (0.83) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL142045 | 0.80 | CHRM3 (0.73) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL143847 | 0.80 | CHRM3 (0.83) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090076061-A1 | MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-03-19 | — | — | US | claimed |
| EP-1781103-A4 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-05-14 | — | — | EP | claimed |
| EP-1781103-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2007-05-09 | — | — | EP | claimed |
| WO-2006017767-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2006-02-16 | — | — | WO | claimed |
| US-20090076061-A1 | MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-03-19 | — | — | US | disclosed |
| EP-1781103-A4 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-05-14 | — | — | EP | disclosed |
| EP-1781103-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006017767-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2006-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076061-A1 | MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNA7, CHRNA2 | CHRM3 1/4885CHRM2 7/4885CHRM1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.